Hypoglycaemia risk requires consideration, particularly in patients with type 2 diabetes taking GLP-1 medications alongside insulin or sulfonylureas
The obtained good 2D classes were used for template-based automatic particle picking, and false positives or bad particles were subsequently eliminated over two rounds of 2D classification, resulting in 9101 selected particles
HA receives research funding from Phenomix Sciences and the USA National Institute of Health (K12AR084222)
It interacts with barrier function, immune activity, oil production, moisture balance, and the local environment
Check your insurance coverage - Schedule consultation Who Actually Benefits From GLP-1 Medications
Read the full Q&A with Tamraz to learn how our pharmacogenetics research is reshaping patient care by reducing adverse drug reactions and expanding access to precision medicine